Literature DB >> 11902829

Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes.

K R Aupperle1, Y Yamanishi, B L Bennett, F Mercurio, D L Boyle, G S Firestein.   

Abstract

IkappaB kinase (IKK) plays a key role in the regulation of nuclear factor kappaB (NF-kappaB). We previously demonstrated the expression of two kinases, IKK1 and IKK2, in fibroblast-like synoviocytes (FLS) and determined their functional consequences for inflammatory gene expression in vitro and in vivo. Recently, a novel inducible IkappaB kinase has been described, namely, IKK-i or IKK-epsilon, which is functionally and structurally distinct from constitutively expressed IKK1 and IKK2. Therefore, we investigated the expression and regulation of this novel kinase in FLS from patients with rheumatoid arthritis and osteoarthritis. Interestingly, constitutive gene expression and protein expression were observed in all cell lines examined. TNFalpha stimulation for 24 h increased IKK-i expression 7.2 +/- 1.8-fold in FLS (P < 0.02). IL-1 also significantly increased IKK-i gene expression. Time course experiments demonstrated that IKK-i gene expression increased within 3 h of TNFalpha stimulation and persisted for at least 24 h. Dose-response studies showed that as little as 1 ng/ml of TNFalpha increased IKK-i gene expression. Constitutive IKK-1 gene expression was also noted in rheumatoid arthritis, osteoarthritis, and normal synovium. This is the first report demonstrating constitutive expression and cytokine regulation of this novel kinase in primary human synovial cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11902829     DOI: 10.1006/cimm.2002.1885

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

Review 1.  Signal transduction networks in rheumatoid arthritis.

Authors:  D Hammaker; S Sweeney; G S Firestein
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Adenosine monophosphate-activated protein kinase activation and suppression of inflammatory response by cell stretching in rabbit synovial fibroblasts.

Authors:  Wanlop Kunanusornchai; Chatchai Muanprasat; Varanuj Chatsudthipong
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

3.  Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene.

Authors:  Naizhen Wang; Salahuddin Ahmed; Tariq M Haqqi
Journal:  Gene       Date:  2005-06-20       Impact factor: 3.688

4.  Update on Targets of Biologic Therapies for Rheumatoid Arthritis.

Authors:  Zafar Rasheed; Tariq M Haqqi
Journal:  Curr Rheumatol Rev       Date:  2008-11-01

5.  Kinetic analysis of synovial signalling and gene expression in animal models of arthritis.

Authors:  Akihisa Fukushima; David L Boyle; Maripat Corr; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2009-05-26       Impact factor: 19.103

6.  Effects of adenovirus-mediated knockdown of IRAK4 on synovitis in the osteoarthritis rabbit model.

Authors:  Muzhe Li; Huiyun Li; Xun Ran; Han Yin; Xuling Luo; Zhiwei Chen
Journal:  Arthritis Res Ther       Date:  2021-12-04       Impact factor: 5.156

7.  Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line.

Authors:  Lu Xie; Brian K Law; Mary E Aakre; Mary Edgerton; Yu Shyr; Neil A Bhowmick; Harold L Moses
Journal:  Breast Cancer Res       Date:  2003-08-20       Impact factor: 6.466

8.  IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.

Authors:  Benjamin Péant; Sophie Gilbert; Cécile Le Page; Alexis Poisson; Emilie L'Ecuyer; Zied Boudhraa; Marc Nicolas Bienz; Nathalie Delvoye; Fred Saad; Anne-Marie Mes-Masson
Journal:  Oncotarget       Date:  2017-02-28

Review 9.  Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses.

Authors:  J Hiscott; T-L A Nguyen; M Arguello; P Nakhaei; S Paz
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.